Profile
Nicholas Robbins-Cherry is currently the Chief Financial Officer, Director & Vice President at Ixaka Ltd. He previously worked as the Finance Director at CACI Ltd. from 2008 to 2013 and at The Marketing Practice (UK) Ltd. from 2013 to 2014.
In 2019, he briefly served as the Secretary at Biodexa Pharmaceuticals Plc.
Nicholas Robbins-Cherry active positions
| Companies | Position | Start |
|---|---|---|
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Director of Finance/CFO | 30/09/2021 |
Former positions of Nicholas Robbins-Cherry
| Companies | Position | End |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Director of Finance/CFO | 08/09/2019 |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Director of Finance/CFO | 31/12/2013 |
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Director of Finance/CFO | 31/12/2012 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Technology Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Commercial Services |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
- Stock Market
- Insiders
- Nicholas Robbins-Cherry
















